| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/29/2001 | CA2142356C Antiperspirant-deodorant cosmetic products |
| 05/29/2001 | CA2049302C Aerosol carriers |
| 05/29/2001 | CA2033725C Pharmaceutical and cosmetic compositions containing a salt of cholanic acid |
| 05/29/2001 | CA2024942C Implantable delivery dispenser |
| 05/29/2001 | CA2019273C Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
| 05/26/2001 | CA2291346A1 Antifungal solutions |
| 05/25/2001 | WO2001036656A2 A complex between hyaluronic acid and a biomolecule and its use |
| 05/25/2001 | WO2001036640A2 Human fgf-21 gene and gene expression products |
| 05/25/2001 | WO2001036611A1 Process for the production of a reversibly inactive acidified plasmin composition |
| 05/25/2001 | WO2001036609A1 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
| 05/25/2001 | WO2001036608A1 Reversibly inactivated acidified plasmin |
| 05/25/2001 | WO2001036583A1 Continuous-flow method for preparing microparticles |
| 05/25/2001 | WO2001036515A2 Polymeric compositions and a method of making the same |
| 05/25/2001 | WO2001036455A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/25/2001 | WO2001036433A2 Synthetic lipid-a analogs and uses thereof |
| 05/25/2001 | WO2001036409A1 Magnesium omeprazole |
| 05/25/2001 | WO2001036394A1 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer |
| 05/25/2001 | WO2001036290A1 Injection-moulded water-soluble container |
| 05/25/2001 | WO2001036078A1 Method for the production of particles |
| 05/25/2001 | WO2001036039A2 Iontophoretic transdermal delivery of peptides |
| 05/25/2001 | WO2001036007A2 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 05/25/2001 | WO2001035999A1 Stable amorphous amifostine composition, and preparation thereof |
| 05/25/2001 | WO2001035998A1 Compositions for transdermal and transmucosal administration of therapeutic agents |
| 05/25/2001 | WO2001035987A1 An aqueous solution formulation of alpha-interferon |
| 05/25/2001 | WO2001035976A1 Treatment or prevention of photoaging and skin cancer |
| 05/25/2001 | WO2001035974A2 Aplidine treatment of cancers |
| 05/25/2001 | WO2001035966A1 Boron compounds and complexes as anti-inflammatory agents |
| 05/25/2001 | WO2001035964A1 Substituted 1-benzazepines and derivatives thereof |
| 05/25/2001 | WO2001035962A1 Solutions containing epinastine |
| 05/25/2001 | WO2001035961A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/25/2001 | WO2001035958A1 Carvedilol methanesulfonate |
| 05/25/2001 | WO2001035953A2 Exercise and muscle enhancement formulations |
| 05/25/2001 | WO2001035949A2 Treatment or systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 05/25/2001 | WO2001035946A2 Intranasal administration of raloxifene and tamoxifen |
| 05/25/2001 | WO2001035943A2 Dextrose and insulin fluid formulation for intravenous infusion |
| 05/25/2001 | WO2001035942A2 Analgesic compositions containing buprenorphine |
| 05/25/2001 | WO2001035941A2 Novel composition based on a thiazolidinedione and metformin and use |
| 05/25/2001 | WO2001035940A2 Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride |
| 05/25/2001 | WO2001035937A2 Lipid complex of alkycyclines |
| 05/25/2001 | WO2001035934A1 Film preparation for biphasic release of pharmacologically active or other substances |
| 05/25/2001 | WO2001035933A2 A method of microencapsulation |
| 05/25/2001 | WO2001035932A2 Sustained drug delivery from structural matrices |
| 05/25/2001 | WO2001035931A2 A film, sheet or wafer-shaped administration |
| 05/25/2001 | WO2001035930A1 Taste masked oral compositions |
| 05/25/2001 | WO2001035929A2 Biodegradable polymer composition |
| 05/25/2001 | WO2001035928A1 Microfabricated devices for the delivery of molecules into a carrier fluid |
| 05/25/2001 | WO2001035927A2 Topical application of muscarinic analgesic drugs such as neostigmine |
| 05/25/2001 | WO2001035926A2 An improved pharmaceutical composition for treating male erectile dysfunction |
| 05/25/2001 | WO2001035925A1 Food product comprising encapsulated drugs |
| 05/25/2001 | WO2001035922A1 Novel positive latex and use in cosmetics |
| 05/25/2001 | WO2001035906A2 Personal care articles comprising a hydrophilic conditioning agent exhibiting a defined leaching value |
| 05/25/2001 | WO2001035905A2 Personal care articles comprising cationic polymer coacervate compositions |
| 05/25/2001 | WO2001035883A1 Transdermal delivery system for alkaloids of aconitum species |
| 05/25/2001 | WO2001035867A2 Ophthalmologic implant |
| 05/25/2001 | WO2001035764A1 Stable, spray-dried composition in a carbohydrate substrate and process for obtaining said composition |
| 05/25/2001 | WO2001013898A3 Pharmaceutical formulations with different release times |
| 05/25/2001 | WO2001012235A3 Targeted artificial gene delivery |
| 05/25/2001 | WO2001010446A3 Formulations for parenteral use of estramustine phosphate and albumin |
| 05/25/2001 | WO2001005362A3 Emulsifier-free finely dispersed water-in-oil-type systems |
| 05/25/2001 | WO2001003678A3 Transdermal therapeutic system for the utilization of tolterodine |
| 05/25/2001 | WO2001000223A3 Multiple agent diabetes therapy |
| 05/25/2001 | WO2000078290A3 Pharmaceutical composition comprising a salt of paroxetine |
| 05/25/2001 | WO2000064426A3 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 05/25/2001 | WO2000061191A3 Heat stable coated colloidal iron oxides |
| 05/25/2001 | WO2000059489A3 Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites |
| 05/25/2001 | WO2000051571B1 Capsule system |
| 05/25/2001 | WO2000042998A9 Multiparticulate bisoprolol formulation |
| 05/25/2001 | WO2000032555A8 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 05/25/2001 | WO2000010588A3 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 05/25/2001 | WO2000010582A8 Probiotic, lactic acid-producing bacteria and uses thereof |
| 05/25/2001 | WO2000001363A3 Enteric coated pharmaceutical formulation |
| 05/25/2001 | CA2685349A1 Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
| 05/25/2001 | CA2392103A1 Human fgf-21 gene and gene expression products |
| 05/25/2001 | CA2392085A1 Carvedilol methanesulfonate |
| 05/25/2001 | CA2391968A1 An improved pharmaceutical composition for treating male erectile dysfunction |
| 05/25/2001 | CA2391889A1 An aqueous solution formulation of alpha-interferon |
| 05/25/2001 | CA2391502A1 Aplidine treatment of cancers |
| 05/25/2001 | CA2391498A1 Substituted 1-benzazepines and derivatives thereof |
| 05/25/2001 | CA2391418A1 Stable amorphous amifostine composition, and preparation thereof |
| 05/25/2001 | CA2391396A1 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer |
| 05/25/2001 | CA2391039A1 Personal care articles comprising a hydrophilic conditioning agent exhibiting a defined leaching value |
| 05/25/2001 | CA2391032A1 Personal care articles comprising cationic polymer coacervate compositions |
| 05/25/2001 | CA2390864A1 Stable, spray-dried composition in a carbohydrate substrate and process for obtaining said composition |
| 05/25/2001 | CA2389613A1 Continuous-flow method for preparing microparticles |
| 05/25/2001 | CA2389487A1 Process for the production of a reversibly inactive acidified plasmin composition |
| 05/25/2001 | CA2388846A1 Novel composition and use |
| 05/25/2001 | CA2388844A1 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
| 05/25/2001 | CA2388705A1 Treatment of sle with dehydroepiandrosterone |
| 05/25/2001 | CA2386873A1 Polymeric compositions and a method of making the same |
| 05/24/2001 | US20010001817 Implantable device and use therefor |
| 05/24/2001 | US20010001799 Anticoagulant |
| 05/24/2001 | US20010001790 Topical formulations comprising skin penetration agents and the use thereof |
| 05/24/2001 | US20010001711 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/24/2001 | US20010001669 Compound delivery using rapidly dissolving collagen film |
| 05/24/2001 | US20010001668 Lozenge for the modified releasing of active substances in the gastrointestinal tract |
| 05/24/2001 | US20010001667 Oil in water(O/W); oily phase dispersed in aqueous phase, containing at least one anionic emulsifier which is liquid at room temperature, and the oily phase is in the form of a soft paste at room temperature; minimizing wrinkles, dry skin |
| 05/24/2001 | US20010001664 An agglomerate of microcrystalline cellulose and silicon dioxide of given particle size in intimate association |
| 05/24/2001 | US20010001658 Granule modulating hydrogel system |
| 05/24/2001 | US20010001657 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 05/23/2001 | EP1101493A2 New combination of formoterol and budesonide |